CARY, N.C.--(BUSINESS WIRE)--Cetero Research, an industry leader in clinical pharmacology, bioanalytical and specialty Phase II-IV services, announces strategic expansions in its bioanalytical operations. Cetero now has a fully operational immunochemistry group in Houston, and its Toronto bioanalytical laboratory has added the newest AB Sciex Triple QuadTM 5500 system.
